HOW TO INVEST IN CANNABIS IN MALI
Investing in cannabis assets presents an exciting opportunity for investors looking to capitalize on the rapidly growing cannabis industry. With the increasing acceptance and legalization of cannabis in various regions, the potential for substantial returns has attracted the attention of many.
This article aims to provide a comprehensive guide on how to invest in cannabis assets from Mali, offering valuable insights and strategies tailored to those interested in this emerging sector.
5 Steps to Follow When Investing in Cannabis Assets from Mali
This section will outline the five essential steps to invest in cannabis assets. These steps provide a concise summary of the investment process. Let's dive in:
Define your goals and investment strategy: Establish your objectives and determine your strategy for investing in cannabis assets. Decide whether you aim for long-term investments or prefer more active trading. Consider questions like, "Will I focus on investing in specific cannabis companies or opt for diversified cannabis-focused funds?" and "What level of risk am I comfortable with?". Develop a sound strategy that aligns with your goals and risk tolerance.
Select the broker that aligns with your strategy: Choosing the right broker is crucial when investing in cannabis assets. Ensure that the broker you select facilitates trading accounts for investors in Mali and specialises in cannabis investments. Some brokers may have restrictions based on residency, so finding one that caters to Malian investors is essential. We provide a list of recommended brokers in the following section.
Open a trading account with your chosen broker and fund it: Most online brokers will require you to complete specific documentation, such as identification (passport or Carte nationale d'identité NINA) and proof of residence (for example, a EDM Bill), through their platform or application. Follow the necessary steps, and the broker will guide you through the account setup process. Within 1-2 days, your account will be ready. Funding options typically include credit cards, bank transfers, and e-wallets. Confirm that the broker supports the funding methods available to you.
Implement your investment strategy: Once your broker confirms that your account is active and you have deposited funds, it's time to implement your investment strategy for cannabis assets. Execute your investment ideas, whether it involves purchasing individual cannabis stocks, investing in cannabis-focused exchange-traded funds (ETFs), or exploring other cannabis-related investment opportunities. Ensure that your investments align with your defined strategy and objectives.
Regularly review your performance and adjust your strategy as necessary: It's essential to regularly assess the performance of your cannabis investments and make adjustments as needed. Analyse your investment decisions, track market trends, and stay informed about the evolving cannabis industry. Learn from any mistakes or missteps along the way and refine your investment strategy accordingly. Remember that investing in cannabis assets is an ongoing process that requires continuous evaluation and improvement.
Conclusion: By following these five steps, you can start investing in cannabis assets. Define your goals and strategy, select a suitable broker, open a trading account, implement your investment strategy, and regularly review your performance. As with any investment, stay informed and adapt your approach as the cannabis industry evolves.
Top Brokers to Trade Cannabis Stocks in Mali
4 Ways to Invest in Cannabis Assets
There are four primary ways to invest in cannabis assets. Although all four ultimately involve investing in stocks, the investment vehicles and level of diversification vary.
Stock picking is when investors select cannabis assets they believe are suitable investments. This involves predicting whether the asset's price will rise or if it will generate significant returns in the future. Stock picking can be challenging because determining an asset's future performance is difficult. Stock picking differs from passive investment management, where investors buy a passively managed cannabis-focused ETF or Mutual Fund.
Stock picking is the most common way for investors to begin investing in cannabis assets. They might say things like, "I want to buy shares of a prominent cannabis company," or "I've heard that the price of XYZ cannabis stock will increase significantly once certain conditions are met."
Charlie Munger, a legendary investor and Warren Buffett's partner at Berkshire Hathaway, wrote "The Art of Stock Picking." He advocates for this approach, arguing that while diversification may decrease portfolio risk, it is impossible to beat the market's performance consistently. Munger's strategy is to select a few cannabis companies he believes in, buy their stocks, and hold onto them for an extended period.
To contrast Munger's investment strategy, another renowned investor, Carl Icahn, has said:
"My investment philosophy, generally, with exceptions, is to buy something when no one wants it."
As a contrarian investor, Icahn identifies cannabis companies with stock prices that reflect poor financial indicators, such as low price-to-earnings (P/E) ratios or book values that exceed the present market valuation.
He then aggressively purchases a significant number of shares in the company and either pushes for the election of an entirely new board of directors or sells the company's unprofitable assets to deliver more value to shareholders.
As you can see, there are different (and contrarian) ways of investing through stock picking. Stock picking is, in essence, the purest form of investing in cannabis assets, but it is not the only one.
Which cannabis stocks are popular?
Some popular cannabis assets include shares of prominent cannabis companies; the following is a list of the most traded ones. Please note that this list is not exhaustive, and popularity may vary.
Canopy Growth Corporation (trades at the NY Stock Exchange under the code: CGC): Canopy Growth is one of the largest cannabis companies globally. They specialise in cultivating, producing, and selling medical and recreational cannabis products. With a diverse portfolio of brands, including Tweed and Spectrum Therapeutics, Canopy Growth is known for its innovation and strategic partnerships within the cannabis industry.
Aurora Cannabis Inc. (NASDAQ: ACB): Aurora Cannabis is a Canadian-based company that produces and distributes medical and recreational cannabis products. They operate a vertically integrated business model, focusing on cultivating, extracting, and distributing cannabis products worldwide. Aurora is recognised for its extensive production capacity and broad product offerings.
Tilray, Inc. (NASDAQ: TLRY): Tilray is a global cannabis company that manufactures, processes, and distributes medical and adult-use cannabis products. They have various brands and products catering to various consumer preferences. Tilray also emphasises research and development initiatives to advance cannabis-based treatments.
Cronos Group Inc. (NASDAQ: CRON): Cronos Group is a vertically integrated cannabis company cultivating, producing, and distributing cannabis and hemp-derived products. They focus on developing brands and partnerships to expand their market reach. Cronos Group also invests in innovative cannabis research and technology to drive industry growth.
Aphria Inc. (NASDAQ: APHA): Aphria is a Canadian cannabis company that produces and distributes medical and recreational cannabis products. They offer diverse brands and products, targeting domestic and international markets. Aphria is known for its strong cultivation capabilities and strategic acquisitions.
HEXO Corp. (NYSE: HEXO): HEXO is a leading cannabis producer based in Canada. They focus on cultivating, manufacturing, and distributing a wide range of cannabis products, including dried flowers, oils, edibles, and beverages. HEXO prioritises innovation and sustainability and aims to provide consistent cannabis experiences.
GW Pharmaceuticals plc (NASDAQ: GWPH): GW Pharmaceuticals is a UK-based biopharmaceutical company specialising in developing cannabinoid-based prescription medicines. Their flagship product, Epidiolex, is an FDA-approved medication used to treat certain forms of epilepsy. GW Pharmaceuticals is dedicated to advancing the therapeutic potential of cannabis-based treatments.
Green Thumb Industries Inc. (CNSX: GTII, OTCMKTS: GTBIF): Green Thumb Industries (GTI) is a US-based cannabis company that operates a vertically integrated business model. They cultivate, process, and distribute a wide range of cannabis products across multiple states in the US. GTI's brand portfolio includes famous names such as Rhythm, Dogwalkers, and Beboe.
Curaleaf Holdings, Inc. (CNSX: CURA, OTCMKTS: CURLF): Curaleaf is a leading vertically integrated cannabis company in the US. They operate in multiple states, offering various cannabis products, including flowers, concentrates, edibles, and topicals. Curaleaf focuses on providing high-quality products and expanding its retail footprint across key markets.
Trulieve Cannabis Corp. (CNSX: TRUL, OTCMKTS: TCNNF): Trulieve is a US-based cannabis company known for its dominant presence in Florida. They cultivate and produce a wide range of cannabis products, serving medical and recreational consumers. Trulieve operates a network of dispensaries and prioritises customer-centric experiences and product innovation.
Organigram Holdings Inc. (NASDAQ: OGI): Organigram is a Canadian cannabis producer specialising in cultivating and producing high-quality cannabis products. They offer a variety of dried flowers, oils, and edibles catering to medical and adult-use markets. Organigram focuses on sustainable growing practices and product innovation.
Village Farms International, Inc. (NASDAQ: VFF): Village Farms is a global agricultural company diversified into cannabis production. Through its subsidiary, Pure Sunfarms, Village Farms cultivates cannabis products for the Canadian market. They leverage their expertise in large-scale greenhouse growing to produce high-quality cannabis at competitive prices.
Another way to invest in cannabis assets is through diversified investment vehicles like exchange-traded funds (ETFs).
ETFs are investment funds that typically hold a portfolio of cannabis stocks, bonds, or a combination of assets. The portfolios can be index-based, such as tracking the Cannabis Stock Index (representing the top cannabis companies by market capitalization) or focusing on specific sectors or industries within the cannabis market.
ETFs differ from traditional mutual funds because they trade on the stock exchange like individual stocks. They can be bought and sold throughout the trading day at market prices.
In recent years, cannabis-focused ETFs have gained popularity due to their low costs, tax efficiency, and ease of trading. Like mutual funds, ETFs offer investors diversified exposure to various cannabis assets, including stocks of cannabis companies.
Which cannabis ETFs are popular?
If you want broad exposure to the cannabis market, you can invest in an ETF that tracks the Cannabis Stock Index (more information later). Some popular cannabis ETF providers include:
ETFMG Alternative Harvest ETF (NYSEARCA: MJ): The ETFMG Alternative Harvest ETF was the first and remains one of the largest cannabis-focused ETFs. It offers exposure to a diversified portfolio of global companies engaged in the legal cultivation, production, and distribution of cannabis products. MJ tracks the Prime Alternative Harvest Index.
AdvisorShares Pure Cannabis ETF (NYSEARCA: YOLO): The AdvisorShares Pure Cannabis ETF aims to provide exposure to the global cannabis industry. It invests in companies across various segments, including cultivation, manufacturing, and distribution. YOLO seeks long-term capital appreciation and tracks the AdvisorShares Pure Cannabis Index.
Global X Cannabis ETF (NASDAQ: POTX): The Global X Cannabis ETF focuses on companies involved in the legal production, growth, and distribution of cannabis and hemp-derived products globally. POTX provides targeted exposure to the cannabis industry, tracking the Cannabis Index from the Indxx.
Amplify Seymour Cannabis ETF (NYSEARCA: CNBS): The Amplify Seymour Cannabis ETF seeks to invest in companies across the cannabis ecosystem. It targets cannabis cultivators, retailers, extractors, and other supporting businesses. CNBS aims to provide exposure to the overall performance of the global cannabis industry.
The Cannabis ETF (NYSEARCA: THCX): The Cannabis ETF provides exposure to a diversified basket of global cannabis companies. It aims to track the Innovation Labs Cannabis Index, which includes companies across various segments, such as cannabis cultivation, extraction, and ancillary services.
Cambria Cannabis ETF (NYSEARCA: TOKE): The Cambria Cannabis ETF focuses on the global cannabis industry, targeting companies engaged in cannabis-related biotechnology, cultivation, and retail. TOKE follows the Cambria Global Cannabis Index.
Investors can buy and sell mutual funds directly from a company at the fund's net asset value (NAV), calculated at the end of each trading day. Like ETFs, mutual funds are portfolios that invest in a mix of cannabis stocks, bonds, or other assets based on a predefined investment strategy.
One significant difference between ETFs and mutual funds is that mutual fund portfolios are usually actively managed and not based on an index. The fund's management team makes the investment decisions according to the fund's strategy. Therefore, investing in mutual funds can provide exposure to cannabis assets if the fund's strategy includes such investments.
Several indexes represent the cannabis market, but let's focus on the Cannabis Stock Index. The Cannabis Stock Index comprises the top cannabis companies listed on various stock exchanges by market capitalisation. It provides a broad representation of the cannabis industry's leading businesses. The index differs from other financial market indices, such as the S&P 500, in terms of the size and composition of its constituents.
It is considered a vital indicator of the cannabis industry's performance. Investing in a financial instrument replicating the Cannabis Stock Index can gain exposure to a significant portion of the cannabis industry through the shares of its most prominent companies.
Bottom line: There are various ways to invest in cannabis assets, ranging from individual stock picking (e.g., "Buying shares of a prominent cannabis company") to more diversified approaches (e.g., purchasing a cannabis-focused ETF or mutual fund).
Cannabis Industry Worldwide: Aspects to Take into Account
Legalisation and Regulation
Cannabis laws and regulations vary widely across countries. Some nations have legalised cannabis for medical and recreational use, while others have decriminalised or permitted limited medical use. The degree of regulation, licensing requirements, and market structure also vary, impacting the industry's growth potential in each jurisdiction.
Medical and Recreational Markets
The cannabis industry encompasses both medical and recreational markets. Medical cannabis is used for therapeutic purposes, treating conditions such as chronic pain, epilepsy, and nausea associated with chemotherapy. Recreational cannabis is consumed for personal enjoyment. The size and regulatory frameworks of these markets differ among countries.
Global Market Size and Growth
The global cannabis market has experienced remarkable growth, driven by increasing legalisation and evolving consumer attitudes. According to various market research reports, global cannabis will reach significant value in the coming years. North America, including the United States and Canada, has emerged as a critical market, with Europe and other regions also experiencing growth.
Cultivation and Production
Cannabis cultivation occurs indoors and outdoors, with different methods to optimise yields and quality. Cultivation techniques range from traditional soil-based methods to advanced hydroponics and aeroponics. Production involves processing harvested cannabis into various forms, such as dried flowers, oils, edibles, concentrates, and topicals.
The cannabis industry has stimulated the growth of various ancillary sectors. These include cannabis testing laboratories, specialised packaging and labelling companies, equipment manufacturers, technology providers, consulting services, and compliance and regulatory firms. Ancillary industries support the growth and development of the cannabis market.
International Trade and Export
As legalisation expands, some countries become vital players in the international cannabis trade. Canada, for example, has emerged as a significant exporter of cannabis products to countries where it is legal. Additionally, various regions are exploring opportunities for international cooperation and trade agreements related to cannabis.
Research and Development
The cannabis industry has opened avenues for research and development, including studies on the plant's therapeutic properties, extraction techniques, and the development of novel cannabis-derived pharmaceuticals. Ongoing research aims to understand better the plant's compounds, potential medical applications, and the development of standardised dosage forms.
Social and Legal Impacts
Cannabis legalisation has had societal and legal impacts. Advocates argue that legalisation promotes social equity, reduces incarceration rates, and generates tax revenue. However, concerns remain regarding public health, underage use, impaired driving, and potential abuse. Balancing regulation and education is crucial for addressing these concerns.
Pros of Investing in the Cannabis Sector
Rapid Industry Growth: The cannabis industry has experienced significant growth in recent years, driven by increasing legalisation and expanding consumer demand. This growth potential presents opportunities for investors to capitalise on a developing market.
Diversification: Investing in the cannabis sector can benefit an investment portfolio. As the industry operates independently of traditional sectors, it can offer a hedge against market volatility and economic cycles.
Expanding Legalization: The trend towards legalising cannabis for medical and recreational use is gaining momentum globally. This creates the potential for increased market size and new investment opportunities as more jurisdictions open up to legal cannabis.
Medical and Wellness Applications: The medical cannabis segment offers potential therapeutic applications in treating chronic pain, epilepsy, and nausea. Increasing research and acceptance of cannabis for medical purposes could drive further growth and revenue in the sector.
Ancillary Industries: Beyond cannabis cultivation and production, numerous ancillary industries support the sector, including technology, packaging, testing, and consulting services. Investing in these ancillary sectors can provide exposure to the cannabis industry's growth without the risks associated with direct cannabis production.
Cons of Investing in the Cannabis Sector
Regulatory Uncertainty: The cannabis industry operates under a complex web of regulations, which can vary significantly from one jurisdiction to another. Regulatory changes, including shifts in government policies or legal setbacks, can pose challenges and create uncertainty for investors.
Market Volatility: The cannabis sector is known for its high volatility, with stock prices subject to significant fluctuations. This volatility can be driven by regulatory developments, market sentiment, and investor speculation, posing risks for investors seeking stability.
Legal and Compliance Risks: Despite increasing legalisation, cannabis remains illegal at the federal level in many countries. This creates legal and compliance risks, as companies operating in the sector must navigate a complex legal landscape. Changes in legal status or enforcement priorities can impact investments in the industry.
Financial Challenges: Many cannabis companies face financial challenges, including limited access to traditional banking services and difficulties obtaining financing. Profitability and cash flow concerns can impact individual companies' financial stability and growth potential.
Market Saturation and Competition: As the cannabis industry grows, competition among companies increases. Oversupply, pricing pressures, and market saturation in certain regions can pose challenges for companies and potentially impact investment returns.
Stigma and Perception: Despite shifting attitudes towards cannabis, there is still a lingering stigma associated with the industry. This can impact public perception, investor sentiment, and government attitudes, potentially hindering the sector's growth and acceptance.
It's important to note that investing in the cannabis sector carries both potential rewards and risks. Thorough due diligence, understanding the regulatory environment, and diversifying investments can help investors navigate the industry's complexities and make informed decisions.
AvaTrade is a renowned Irish brokerage firm offering exceptional stock trading experience for investors looking to tap into the global markets. With its user-friendly platform and extensive range of tradable stocks, AvaTrade stands out as a top choice for stock trading enthusiasts.
One of the key highlights of AvaTrade's stock trading service is its vast selection of global stocks. From major exchanges such as the New York Stock Exchange (NYSE) to popular international markets like the London Stock Exchange (LSE), AvaTrade provides access to a diverse range of stocks across various sectors and regions. This enables traders to build a diversified, well-rounded portfolio tailored to their investment goals.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.